229 related articles for article (PubMed ID: 11966755)
1. Prospects for immune reconstitution in HIV-1 infection.
Imami N; Gotch F
Clin Exp Immunol; 2002 Mar; 127(3):402-11. PubMed ID: 11966755
[No Abstract] [Full Text] [Related]
2. Immune reconstitution in HIV-1-infected patients.
Imami N; Hardy G; Pires A; Burton C; Pido-Lopez J; Mela C; Gotch F
Curr Opin Investig Drugs; 2002 Aug; 3(8):1138-45. PubMed ID: 12211404
[TBL] [Abstract][Full Text] [Related]
3. T cells versus HIV-1: fighting exhaustion as well as escape.
Robinson HL
Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971
[No Abstract] [Full Text] [Related]
4. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
5. [HIV vaccination].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
[No Abstract] [Full Text] [Related]
6. Editorial: Lymph Node T Cell Dynamics and Novel Strategies for HIV Cure.
Petrovas C; Velu V
Front Immunol; 2018; 9():2950. PubMed ID: 30619310
[No Abstract] [Full Text] [Related]
7. Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategies.
Burton CT; Mela CM; Rosignoli G; Westrop SJ; Gotch FM; Imami N
Curr Med Chem; 2006; 13(26):3203-11. PubMed ID: 17168707
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy and therapeutic vaccines in HIV infection.
García F; Ruiz L; López-Bernaldo de Quirós JC; Moreno S; Domingo P
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():84-104. PubMed ID: 16373008
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic vaccines and immunotherapy revisited.
Gotch F
J HIV Ther; 2005 Sep; 10(3):48-50. PubMed ID: 16385971
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.
Jin X; Ramanathan M; Barsoum S; Deschenes GR; Ba L; Binley J; Schiller D; Bauer DE; Chen DC; Hurley A; Gebuhrer L; El Habib R; Caudrelier P; Klein M; Zhang L; Ho DD; Markowitz M
J Virol; 2002 Mar; 76(5):2206-16. PubMed ID: 11836398
[TBL] [Abstract][Full Text] [Related]
11. Update from the 5th International AIDS Vaccine Conference. Looking for ways to stimulate the immune system.
Wakefield S; Fisher K
Posit Aware; 2006; 17(6):29. PubMed ID: 17233087
[No Abstract] [Full Text] [Related]
12. Immunisation with gp160 in HIV-1 infection.
Fiala C; Stewart GT
Lancet; 1999 Sep; 354(9182):948; author reply 949. PubMed ID: 10489976
[No Abstract] [Full Text] [Related]
13. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis-immune reconstitution inflammatory syndrome in HIV: from pathogenesis to prediction.
Gopalan N; Andrade BB; Swaminathan S
Expert Rev Clin Immunol; 2014 May; 10(5):631-45. PubMed ID: 24580108
[TBL] [Abstract][Full Text] [Related]
15. Immunologic approaches to the therapy of HIV-1 infection.
Sneller MC; Lane HC
Ann N Y Acad Sci; 1993 Jun; 685():687-96. PubMed ID: 8363275
[No Abstract] [Full Text] [Related]
16. Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection.
Lange CG; Lederman MM
J Antimicrob Chemother; 2003 Jan; 51(1):1-4. PubMed ID: 12493779
[No Abstract] [Full Text] [Related]
17. HIV-1 therapeutic vaccines.
Kinloch-de Loes S; Autran B
J Infect; 2002 Apr; 44(3):152-9. PubMed ID: 12099741
[TBL] [Abstract][Full Text] [Related]
18. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
[TBL] [Abstract][Full Text] [Related]
19. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy.
Connick E
J Investig Dermatol Symp Proc; 2001 Dec; 6(3):212-8. PubMed ID: 11924830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
